Hi MB, I trust you are well?Can you please elaborate on your...

Hi MB, I trust you are well?

Can you please elaborate on your second sentence per below.

IMHO, today's sell-off was a Solomon family group of companies related event (EDE/TAS/CNJ) i.e. I believe that it had nothing to do with the impending MTJV assay results (unless there was a leak?).

Further, whilst I hear plenty of speculation about funding/solvency, it was interesting to hear feedback relating to the call with GLP.

With regard to the funding, the auditor Nexia, per Annual Report to Shareholders (30/9/22) in its entirity including expression ongoing considerations (too many references to mention however Note 1 R stuck out) provided me atleast, with a strong view as to impending need for a CR. Then we had the the Quarterly Activities/Appendix 5B Cash Flow Report (31/10/22) which surprised me personally to the turn of a few million.

In fairness, I understand bills need to get paid however, when you consider the last two reports and balances available I am quite confused as to why a CR was not undertaken pre last exploration update? Prior to the exp update and the hit to the SP that has yet to bench out, they had far better leverage. I have tried to look at it from different positions however, even if we hit something extraordinary, we still needed (need) a CR sooner than later.

If anyone has a view or an alternate position which sheds light on this, Id welcome it. Ive read and re read these reports to death and struggle to see this as an oversight.